BioSpace News Archive

Vitti Labs, an AATB Accredited Tissue Bank focused on life Science Research, development, and manufacturing, announced today that the U.S. Food and Drug Administration (FDA) has approved their Investigational New Drug Application (IND).

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, announced today that the company will release its 2022 first quarter financial results after the market closes on Monday, May 16, 2022.

Amgen released its 2021 Environmental, Social & Governance report, providing a comprehensive overview of the many ways the Company is doing its part to build a better, healthier world.

Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that pharma grade raw materials were purchased for the manufacture of PRP in preparation for the Phase I First-In-Human (FIH) study in advanced cancer patients suffering from solid tumors.

Voxeleron, a cloud-based platform provider that analyzes and tracks all formats of ophthalmic data, today announced the availability of iNebula, a digital media platform specifically developed to optimize ophthalmic clinical trial management.

Athersys, Inc., announced that Dan Camardo, Chief Executive Officer, and Ivor Macleod, Chief Financial Officer, will participate in a fireside chat at the Bank of America Securities 2022 Global Healthcare Conference on Wednesday, May 11, 2022 at 4:00 p.m. PT in Las Vegas.

Ingenia Therapeutics and Mosaic Biosciences today announced the presentation of new data on pharmacokinetically-enhanced variants of IGT-427, Ingenia’s bispecific antibody that potently blocks VEGF and activates Tie-2.

Boston Scientific Corporation will participate in Bank of America’s Global Healthcare Conference on Thursday, May 12.

RedShift BioAnalytics (RedShiftBioⓇ) announces the launch of Apollo, the company’s latest system using ground-breaking MMS technology.

Medical Registries Translate Research into Actionable Insights to Empower Patient Care.